Severe hepatocellular disease in mice lacking one or both CaaX prenyltransferases.
about
Targeting protein prenylation in progeriaInhibitors of protein geranylgeranyltransferase-I lead to prelamin A accumulation in cells by inhibiting ZMPSTE24Mass spectrometry captures off-target drug binding and provides mechanistic insights into the human metalloprotease ZMPSTE24.Inhibition of farnesyl pyrophosphate synthase improves pressure overload induced chronic cardiac remodelingTargeting GGTase-I activates RHOA, increases macrophage reverse cholesterol transport, and reduces atherosclerosis in mice.Disruption of lamin B1 and lamin B2 processing and localization by farnesyltransferase inhibitors.
P2860
Severe hepatocellular disease in mice lacking one or both CaaX prenyltransferases.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Severe hepatocellular disease in mice lacking one or both CaaX prenyltransferases.
@ast
Severe hepatocellular disease in mice lacking one or both CaaX prenyltransferases.
@en
type
label
Severe hepatocellular disease in mice lacking one or both CaaX prenyltransferases.
@ast
Severe hepatocellular disease in mice lacking one or both CaaX prenyltransferases.
@en
prefLabel
Severe hepatocellular disease in mice lacking one or both CaaX prenyltransferases.
@ast
Severe hepatocellular disease in mice lacking one or both CaaX prenyltransferases.
@en
P2093
P2860
P356
P1476
Severe hepatocellular disease in mice lacking one or both CaaX prenyltransferases
@en
P2093
Gregory W Lawson
Loren G Fong
Martin O Bergo
Sandy Y Chang
Shao H Yang
P2860
P356
10.1194/JLR.M021220
P577
2011-10-28T00:00:00Z